Romark
Pharmaceutical company
Based in FL
🤖
AI Overview
With $140K in lobbying spend across 8 quarterly filings, Romark is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2021 to 2023.
$140K
Total Spend
3
Years Active
1
Firms Hired
5
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $60K |
| 2022 | $80K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Disaster Planning, MED
- •Raising profile of therapy and impact on pandemic mitigation.
- •Clinical trials for therapies
- •ARPA, emergency use authorization for COVID-19 therapeutic
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.